Alan B. Bloch
Centers for Disease Control and Prevention
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alan B. Bloch.
American Journal of Public Health | 1990
Alan B. Bloch; S L Stramer; J D Smith; H S Margolis; H A Fields; T W McKinley; Charles P. Gerba; J E Maynard; R K Sikes
An outbreak of hepatitis A occurred in a north Georgia trailer park served by a private well. Of 18 residents who were serosusceptible to hepatitis A virus (HAV), 16 (89%) developed hepatitis A. Well water samples were collected 3 months after illness onset in the index case and 28 days after illness onset in the last trailer park resident. Hepatitis A virus antigen (HAVAg) was detected in the samples by enzyme immunoassay from three of the five cell lines following two 30-day passages and from a fourth cell line following a third passage of 21 days.
AIDS | 1996
Robert W. Shafer; Alan B. Bloch; Christina Larkin; Viswanath Vasudavan; Stephen Seligman; Jack DeHovitz; George T. DiFerdinando; Rand L. Stoneburner; George M. Cauthen
ObjectiveTo ascertain predictors of survival in HIV-infected tuberculosis (TB) patients. DesignRetrospective cohort study. SettingNew York City public hospital. PatientsFifty-four consecutive HIV-seropositive patients with newly diagnosed TB and no other AIDS-defining illnesses. Main outcome measuresCD4+ T-lymphocyte counts, completion of anti-TB therapy, repeat hospitalizations with TB, and survival. ResultsForty-five (84%) of the 54 patients died a median of 15 months after TB diagnosis (range, 1–80 months), five (9%) were alive after a median of 81 months (range, 75–84 months), and four (7%) were lost to follow-up after a median of 42 months (range, 30–66 months). In univariate analyses, disseminated TB, intrathoracic adenopathy, oral candidiasis and CD4 count depletion were each associated with decreased survival. In a multivariate analysis, CD4 count depletion was the only independent predictor of decreased survival. Repeat hospitalization with TB occurred in 10 out of 15 patients who did not complete anti-TB therapy compared with one out of 21 patients who completed anti-TB therapy (P < 0.001). ConclusionThe clinical presentation of TB and CD4 count at TB diagnosis are each predictive of survival in HIV-seropositive TB patients. The CD4 count is the only independent predictor of survival.
JAMA | 1994
Alan B. Bloch; George M. Cauthen; Ida M. Onorato; Kenneth G. Dansbury; Gloria D. Kelly; Cynthia R. Driver; Dixie E. Snider
JAMA | 1989
Hans L. Rieder; George M. Cauthen; Gloria D. Kelly; Alan B. Bloch; Dixie E. Snider
JAMA | 1992
Samuel W. Dooley; Margarita E. Villarino; Mercedes Lawrence; Louis Salinas; Samuel Amil; John V. Rullan; William R. Jarvis; Alan B. Bloch; George M. Cauthen
JAMA Internal Medicine | 1989
Hans L. Rieder; George M. Cauthen; Alan B. Bloch; Clifford H. Cole; Deborah Holtzman; Dixie E. Snider; William J. Bigler; John J. Witte
The Journal of Infectious Diseases | 1990
Mary D. Hutton; William W. Stead; George M. Cauthen; Alan B. Bloch; William M. Ewing
Pediatrics | 1985
Alan B. Bloch; Walter A. Orenstein; William M. Ewing; William H. Spain; George F. Mallison; Kenneth L. Herrmann; Alan R. Hinman
Chest | 1991
Hans L. Rieder; Gloria D. Kelly; Alan B. Bloch; George M. Cauthen; Dixie E. Snider
Pediatric Infectious Disease Journal | 1988
Dixie E. Snider; Hans L. Rieder; Debra Combs; Alan B. Bloch; Christopher H. Hayden; Margaret H. D. Smith